Role of homologous recombination/recombineering on human adenovirus genome engineering: Not the only but the most competent solution
Adenoviruses typically cause mild illnesses, but severe diseases may occur primarily in immunodeficient individuals, particularly children. Recently, adenoviruses have garnered significant interest as a versatile tool in gene therapy, tumor treatment, and vaccine vector development. Over the past tw...
Main Authors: | Lisa-Marie Dawson, Montaha Alshawabkeh, Katrin Schröer, Fatima Arakrak, Anja Ehrhardt, Wenli Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-03-01
|
Series: | Engineering Microbiology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2667370324000031 |
Similar Items
-
HEHR: Homing Endonuclease-Mediated Homologous Recombination for Efficient Adenovirus Genome Engineering
by: Katrin Schröer, et al.
Published: (2022-11-01) -
Adenovirus as a Vector and Oncolytic Virus
by: Wataru Matsunaga, et al.
Published: (2023-06-01) -
Expanding the Spectrum of Adenoviral Vectors for Cancer Therapy
by: Jian Gao, et al.
Published: (2020-05-01) -
The Adenovirus Vector Platform: Novel Insights into Rational Vector Design and Lessons Learned from the COVID-19 Vaccine
by: Erwan Sallard, et al.
Published: (2023-01-01) -
Non-Human Primate-Derived Adenoviruses for Future Use as Oncolytic Agents?
by: Selas T.F. Bots, et al.
Published: (2020-07-01)